Jean-Paul Bahary - Concepedia

Author

Jean-Paul Bahary

Centre Hospitalier de l’Université de Montréal

Also Known As

Jean-Paul Bahary

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier de l’Université de Montréal Medical College of Wisconsin Hôpital Notre-Dame NRG Oncology Mayo Clinic in Arizona

About

Jean-Paul Bahary is an author at Centre Hospitalier de l’Université de Montréal specializing in radiation oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	2K
2	Health Sciences	7	7	1.6K
3	Radiation Medicine	5	5	305
4	Neurology	1	1	26
5	Pharmacology	1	1	22

Jean-Paul Bahary

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial Paul D. Brown, Karla V. Ballman, Jane H. Cerhan, The Lancet Oncology Neuro-oncologyHealth SciencesRadiation TherapyInterdisciplinary NeurosurgerySurgery	2017	1.2K
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma Jan C. Buckner, Edward G. Shaw, Stephanie L. Pugh, New England Journal of Medicine	2016	1K
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer William U. Shipley, Wendy Seiferheld, Himanshu Lukka, New England Journal of Medicine	2017	648
Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: Initial report of radiation therapy oncology group protocol 90-05 Edward Shaw, Charles Scott, Luís Souhami, International Journal of Radiation OncologyBiologyPhysics	1996	281
Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial Abdenour Nabid, Nathalie Carrier, André‐Guy Martin, European Urology UrologyHigh-risk Prostate CancerGenitourinary CancerMedicineBrachytherapy	2018	202
Association of<i>MGMT</i>Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide Erica H. Bell, Barbara J. Fisher, David R. Macdonald, JAMA Oncology	2018	198
Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole-Brain Radiation Therapy Versus WBRT Plus Stereotactic Radiosurgery in Patients With 1-3 Brain Metastases; Poststratified by the Graded Prognostic Assessment (GPA) Paul W. Sperduto, Ryan Shanley, Xianghua Luo, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyNeuro-oncologyRadiation TherapyMedicineRtog 9508	2014	173
Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424 Barbara J. Fisher, Chen Hu, David Macdonald, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyRadiation MedicineRadiation TherapyGliomaMedicine	2015	158
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer Himanshu Lukka, Stephanie L. Pugh, Deborah Watkins Bruner, International Journal of Radiation OncologyBiologyPhysics UrologySurgical OncologyGenitourinary CancerMedicineOutcomes Research	2018	73
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424 Barbara J. Fisher, Stephanie L. Pugh, David Macdonald, International Journal of Radiation OncologyBiologyPhysics Long-term ResultsNeuro-oncologyRadiation MedicineRadiation TherapyMedicine	2020	53

Page 1